Radiotherapy for NSCLC: Review of conventional and new treatment techniques

Journal of Infection and Public Health

Volumn 5, Issue 5 SUPPL.1, 2012, Pages

  Saadeddin, Ahmed ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Lung cancer; NSCLC; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCURACY; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL TARGET VOLUME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONVENTIONAL RADIOTHERAPY; DIAGNOSTIC ACCURACY; DOSIMETRY; GROSS TUMOR VOLUME; HUMAN; IMAGE GUIDED RADIATION DELIVERY; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE; OVERALL SURVIVAL; PLANNING TARGET VOLUME; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RISK ASSESSMENT; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY;

EID: 84870928708     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2012.09.002     Document Type: Article

References (10)

1. Liao Z.X., Komaki R.R., Thames H.D., Liu H.H., Tucker S.L., Mohan R., et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. International Journal of Radiation Oncology Biology Physics 2010, 76(3):775-781.
2. Yom S.S., Liao Z., Liu H.H., Tucker S.L., Hu C.S., Wei X., et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. International Journal of Radiation Oncology Biology Physics 2007, 68:94-102.
3. Brianzoni E., Rossi G., Ancidei S., Berbellini A., Capoccetti F., Cidda C., et al. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume. European Journal of Nuclear Medicine and Molecular Imaging 2005, 32:1392-1399.
4. Ashamalla H., Rafla S., Parikh K., Mokhtar B., Goswami G., Kambam S., et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. International Journal of Radiation Oncology Biology Physics 2005, 63(4):1016-1102.
5. Curran W.J., Scott C.B., Langer C.J., Komaki R., Lee J.S., Hauser S., et al. Long term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresectable NSCLC:RTOG 9410. Proceedings of the American Society of Clinical Oncology 2003, 22:621a.
6. Macapinlac H. Clinical applications of positron emission tomography/computedtomography treatment planning. Seminars in Nuclear Medicine 2008, 38:137-140.
7. Erdi Y.E., Rosenzweig K., Erdi A.K., Macapinlac H.A., Hu Y.C., Braban L.E., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiotherapy and Oncology 2002, 62:51-60.
8. Xia T., Li H., Sun Q., Wang Y., Fan N., Yu Y., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small cell lung cancer. International Journal of Radiation Oncology Biology Physics 2006, 66:117-125.
9. Timmerman R., McGarry R., Yiannoutsos C., Papiez L., Tudor K., DeLuca J., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. Journal of Clinical Oncology 2006, 24:4833-4839.
10. Chang J.Y., Liu H., Komaki R. Intensity-modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Current Oncology Reports 2005, 7:255-259.